Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | EIF2AK4 | Q9P2K8 | 2/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | KHK | P50053 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.32 |
| ▸ | RAF1 | P04049 | 1/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30867912 | 0.94 | GPR119 (0.35) | GPR119SYKEIF2AK4DDB1CRBN | |
| SCHEMBL30868030 | 0.92 | SYK (0.33) | GPR119SYKEIF2AK4DDB1CRBN | |
| SCHEMBL30867868 | 0.92 | SYK (0.33) | GPR119SYKEIF2AK4DDB1CRBN | |
| SCHEMBL30867755 | 0.92 | SYK (0.33) | GPR119SYKEIF2AK4DDB1CRBN | |
| SCHEMBL38654231 | 0.90 | CCR2 (0.32) | CCR2KCNH2KHKRAF1 | |
| SCHEMBL30867891 | 0.90 | CCR2 (0.33) | CCR2KCNH2KHKRAF1 | |
| SCHEMBL38654191 | 0.90 | GPR119 (0.35) | GPR119SYKEIF2AK4DDB1CRBN | |
| SCHEMBL38653831 | 0.90 | GPR119 (0.35) | GPR119SYKEIF2AK4DDB1CRBN | |
| SCHEMBL38653945 | 0.89 | GPR119 (0.31) | GPR119EIF2AK4 | |
| SCHEMBL30867703 | 0.89 | KHK (0.32) | CCR2KCNH2KHKRAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598917-A1 | HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF | Amgen Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| WO-2024076674-A1 | HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF | AMGEN INC. (US) | 2024-04-11 | — | — | WO | disclosed |